Submit your PPH claim details for a free, no obligation case review.
Get Started:
more_legal_areas PPHThere are a number of medical options available for the management of primary pulmonary hypertension. Primary pulmonary hypertension is an unpreventable, incurable rare lung disorder where a person''s blood pressure rises far above normal for no discernable reason. This condition can ultimately lead to heart failure. Women aged 21 to 40 are the group most likely to suffer from primary pulmonary hypertension. Though the exact cause of this condition is often unknown, primary pulmonary hypertension has been linked to the use of appetite suppressants such as fenfluramine (fen-fen) and dexfenfluramine.
Management of primary pulmonary hypertension includes making healthy lifestyle choices, the use of medicines, and in some cases, a lung transplant. To facilitate successful management of primary pulmonary hypertension, women are often advised not to get pregnant. The combination of primary pulmonary hypertension and pregnancy carries a high mortality rate. There are techniques conducive to the management of primary pulmonary hypertension that may be employed to help a woman with primary pulmonary hypertension successfully deliver a child, but there are serious risks to maternal health that patients should understand.
Lifestyle choices can be a major part of the management of primary pulmonary hypertension. A healthy diet, moderate exercise, stress relieving activities, and avoiding cigarettes can be major lifestyle choices that can facilitate successful management of primary pulmonary hypertension. People who live at higher altitudes can more to a lower altitude where the air is not so thin and more oxygen-rich. Many people who incorporate these lifestyle choices into their management of primary pulmonary hypertension can carry on normal daily activities as long as they do not over exert themselves.
A variety of drug treatments are available to support the management of primary pulmonary hypertension. Twenty five to fifty percent of primary pulmonary hypertension patients can be treated with oral calcium channel blocking drugs which improve the heart''s ability to pump blood. Vasodilators can help patients with more advanced conditions or those which do not respond to calcium blockers. Prostacyclin is a treatment administered intravenously through a small pump which can improve pulmonary hypertension. Anticoagulants can reduce the occurrence of blood clots and diuretics can reduce the amount of fluid in the body, both of which aid the management of primary pulmonary hypertension.
Lung transplants may also be an option in the management of primary pulmonary hypertension. In most cases, a single lung transplant is most appropriate for the management of primary pulmonary hypertension. The prognosis following this procedure is generally favorable, with a seventy percent survival rate in the first year following transplant surgery. If you are interested in learning more about the management of primary pulmonary hypertension, you may wish to speak to your medical physician. This professional will be able to evaluate your condition to determine the best management of primary pulmonary hypertension techniques for you.